ALEXANDRIA, Virginia, June 24 -- KITE PHARMA, INC., Santa Monica, California has been assigned a patent (No. US 12337035 B2, initially filed March 25, 2022) developed by five inventors Jonathan Belk, Grantham, New Hampshire; Eugene Bolotin, Berkeley, California; Raghavender Chivukula, Hayward, California; Matthew Drever, Concord, California; and Edward Hai Dhow Liao, Petaluma, California, for "TACI binding molecules."  more